CYMABAY

At CymaBay, we are committed to improving the lives of patients with liver and other chronic diseases by developing and providing access to innovative therapies... We are a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. With a long history of drug discovery and development, we deliver value to all stakeholders through a deep understanding of the underlying mechanisms of inflammation and fibrosis, unique targets that play a role in their progression, and innovative therapies for liver and chronic diseases.

Also known as: CymaBay Therapeutics, CymaBay Therapeutics, Inc.

Primary location: Newark United States